Triple-negative breast cancer

Open Access
The Prognostic Impact of HER2 Status and Survival Outcomes in Metastatic Triple Negative Breast Cancer
ALPER TURKEL, ECE BAYDAR, RÜMEYSA ÇOLAK, AHMET EMİN ÖZTÜRK, TEOMAN ŞAKALAR, SİNEM AKBAŞ, HASİBE BİLGE GÜR, EYYÜP ÇAVDAR, MESUT YILMAZ, DEVRİM ÇABUK, FATİH SELÇUKBİRİCİK, İLHAN HACIBEKİROĞLU and MUTLU DOGAN

In Vivo November 2025, 39 (6) 3617-3625; DOI: https://doi.org/10.21873/invivo.14160
Open Access
Accessing Apoptosis Induction and Metastasis Inhibition Effect of Magnolol on Triple Negative Breast Cancer In Vitro
YU-CHING LI, CHUI-NA WONG, FEI-TING HSU, JIANN-HWA CHEN, CHUNG-CHI YANG, HENG-HAO LIU, WEI-LUNG CHEN and YUEH-SHAN WENG

In Vivo May 2023, 37 (3) 1028-1036; DOI: https://doi.org/10.21873/invivo.13177
Open Access
Clinicopathological and Prognostic Significance of Programmed Death Ligand-1 SP142 Expression in 132 Patients With Triple-negative Breast Cancer
JINAH CHU, MIN-KYUNG YEO, SANG HWA LEE, MI YEON LEE, SEOUNG WAN CHAE, HYUN-SOO KIM and SUNG-IM DO

In Vivo November 2022, 36 (6) 2890-2898; DOI: https://doi.org/10.21873/invivo.13030
Open Access
Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells
JI SUN LEE, YUNMOON OH, JIN-SOL LEE, JAE HYEON PARK, JOO-KYUNG SHIN, JOO-HEE HAN, HYUNG SIK KIM and SUNGPIL YOON

In Vivo September 2022, 36 (5) 2105-2115; DOI: https://doi.org/10.21873/invivo.12936
You have access
Salmonella typhimurium A1-R Exquisitely Targets and Arrests a Matrix-producing Triple-negative Breast Carcinoma in a PDOX Model
KAZUYUKI HAMADA, YUSUKE AOKI, JUN YAMAMOTO, CHIHIRO HOZUMI, MING ZHAO, TAKUYA MURATA, NORIHIKO SUGISAWA, MICHAEL BOUVET, TAKUYA TSUNODA and ROBERT M. HOFFMAN

In Vivo November 2021, 35 (6) 3067-3071; DOI: https://doi.org/10.21873/invivo.12602
You have access
Neo-Bioscore in Guiding Post-surgical Therapy in Patients With Triple-negative Breast Cancer Who Received Neoadjuvant Chemotherapy
YORIKO HASEGAWA, NOBUAKI MATSUBARA, TAKAHIRO KOGAWA, YOICHI NAITO, KENICHI HARANO, AKO HOSONO, TATSUYA ONISHI, TAKASHI HOJO, MOTOTSUGU SHIMOKAWA and TORU MUKOHARA

In Vivo March 2021, 35 (2) 1041-1049; DOI: https://doi.org/10.21873/invivo.12348
You have access
Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) Model
HYE IN LIM, JUN YAMAMOTO, QINHONG HAN, YU SUN, HIROTO NISHINO, YOSHIHIKO TASHIRO, NORIHIKO SUGISAWA, YUYING TAN, HEE JUN CHOI, SEOK JIN NAM, MICHAEL BOUVET and ROBERT M. HOFFMAN

In Vivo November 2020, 34 (6) 3163-3169; DOI: https://doi.org/10.21873/invivo.12151
You have access
Oral Methioninase Inhibits Recurrence in a PDOX Mouse Model of Aggressive Triple-negative Breast Cancer
HYE IN LIM, KAZUYUKI HAMADA, JUN YAMAMOTO, QINHONG HAN, YUYING TAN, HEE JUN CHOI, SEOK JIN NAM, MICHAEL BOUVET and ROBERT M. HOFFMAN

In Vivo September 2020, 34 (5) 2281-2286; DOI: https://doi.org/10.21873/invivo.12039
You have access
Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast Cancer
NIKOLAOS GARMPIS, CHRISTOS DAMASKOS, ANNA GARMPI, KONSTANTINOS NIKOLETTOS, DIMITRIOS DIMITROULIS, EVANGELOS DIAMANTIS, PARASKEVI FARMAKI, ALEXANDROS PATSOURAS, ERRIKA VOUTYRITSA, ATHANASIOS SYLLAIOS, CONSTANTINOS G. ZOGRAFOS, EFSTATHIOS A. ANTONIOU, NIKOS NIKOLETTOS, ALKIVIADIS KOSTAKIS, KONSTANTINOS KONTZOGLOU, DIMITRIOS SCHIZAS and AFRODITI NONNI

In Vivo July 2020, 34 (4) 1715-1727; DOI: https://doi.org/10.21873/invivo.11965
You have access
Shining a Light on the Effects of the Combination of (–)-Epigallocatechin-3-gallate and Tapentadol on the Growth of Human Triple-negative Breast Cancer Cells
SABRINA BIMONTE, MARCO CASCELLA, ANTONIO BARBIERI, CLAUDIO ARRA and ARTURO CUOMO

In Vivo September 2019, 33 (5) 1463-1468; DOI: https://doi.org/10.21873/invivo.11625

Main menu

User menu

Search

Triple-negative breast cancer

Pages